Status:
RECRUITING
The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:
Lead Sponsor:
Diakonie-Klinikum Stuttgart
Collaborating Sponsors:
University Hospital Tuebingen
Conditions:
Prospective
Randomized
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to investigate the analgesic efficacy of the pericapsular nerve group (PENG) block during the implantation of hip endoprostheses. The study is designed as a prospective random...
Eligibility Criteria
Inclusion
- planned cementless hip TEP operation for primary coxarthrosis via minimally invasive anterolateral approach using the identical implant system (Taperloc stem, Plamafit cup)
- Patient capable of giving consent
- Informed consent has been obtained
- age \> 18 years
Exclusion
- Refusal to participate in the study
- Regular use of opioids
- Known chronic pain symptoms
- Infections in the area of the puncture site
- Presence of a contraindication to ropivacaine
- Presence of a contraindication to metamizole
- Presence of a contraindication to postoperative analgesia with diclofenac
- Secondary forms of osteoarthritis with deformities (i.e. high-grade dysplasia, secondary conditions after trauma, secondary conditions after childtrauma, secondary conditions after childhood hip joint diseases
- Spinopelvic dysbalance, spinal canal stenosis
- Previous operations on the hip/pelvis
Key Trial Info
Start Date :
March 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06557044
Start Date
March 7 2024
End Date
March 1 2025
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diakonie-Klinikum Stuttgart
Stuttgart, Baden-Wurttemberg, Germany, 70176